Drug Shortage Report for ACT CLARITHROMYCIN XL

Last updated on 2023-04-28 History
Report ID 119901
Drug Identification Number 02403196
Brand name ACT CLARITHROMYCIN XL
Common or Proper name CLARITHROMYC FC TABLETS 500MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-08
Estimated end date Unknown
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2023-04-28 English Compare
v18 2023-04-27 French Compare
v17 2023-04-27 English Compare
v16 2022-03-17 French Compare
v15 2022-03-17 English Compare
v14 2021-06-30 French Compare
v13 2021-06-30 English Compare
v12 2021-06-17 French Compare
v11 2021-06-17 English Compare
v10 2021-01-14 French Compare
v9 2021-01-14 English Compare
v8 2021-01-07 French Compare
v7 2021-01-07 English Compare
v6 2020-08-13 French Compare
v5 2020-08-13 English Compare
v4 2020-07-16 French Compare
v3 2020-07-16 English Compare
v2 2020-07-09 French Compare
v1 2020-07-09 English Compare

Showing 1 to 19 of 19